Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial.

Trenoska Basile, V; Newton-John, T; Wootton, BM

Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial.

Trenoska Basile, V Newton-John, T

Wootton, BM

Permalink

Publisher:: BMC
Publication Type:: Journal Article
Citation:: Trials, 2022, 23, (1), pp. 592
Issue Date:: 2022-07-23

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download full textAdobe PDF (1.03 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Trenoska Basile, V
dc.contributor.author	Newton-John, T https://orcid.org/0000-0003-4219-4985
dc.contributor.author	Wootton, BM
dc.date.accessioned	2022-09-28T00:15:44Z
dc.date.available	2022-07-06
dc.date.available	2022-09-28T00:15:44Z
dc.date.issued	2022-07-23
dc.identifier.citation	Trials, 2022, 23, (1), pp. 592
dc.identifier.issn	1745-6215
dc.identifier.issn	1745-6215
dc.identifier.uri	http://hdl.handle.net/10453/162151
dc.description.abstract	BACKGROUND: Generalized anxiety disorder (GAD) is a chronic mental health condition that results in a significant individual and societal burden. While cognitive behavioral therapy (CBT) is well established as an efficacious treatment for GAD, many patients experience logistical barriers when accessing face-to-face CBT. Remotely delivered treatments remove many of these barriers. Despite emerging evidence demonstrating the efficacy of remotely delivered CBT for GAD, studies examining the efficacy of remote methods for GAD that are analogous to standard face-to-face treatment, in particular synchronous treatments such as CBT delivered via online videoconferencing (VCBT), are needed. METHODS: The authors propose a two-group randomized controlled trial comparing the efficacy of VCBT for GAD against a waitlist control group. The recruitment target will be 78 adults with primary GAD of at least moderate severity. The manualized high-intensity VCBT intervention will be delivered weekly over a 10-week period. After treatment completion, waitlist participants will receive the same VCBT delivered in a brief format (i.e., weekly over a 5-week period). Treatment for both groups will be delivered in real time via an online teleconferencing platform. Outcome measures will be administered at baseline, mid-treatment, post-treatment, and 3-month follow-up. DISCUSSION: This trial will report findings on the efficacy of a remote synchronous high-intensity VCBT intervention for GAD. The results have the potential to contribute towards advancing our knowledge on the evidence base for GAD, as well as increase the dissemination of VCBT for GAD. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12621000786897 . Registered on 22 June 2021.
dc.format	Electronic
dc.language	eng
dc.publisher	BMC
dc.relation.ispartof	Trials
dc.relation.isbasedon	10.1186/s13063-022-06520-5
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences
dc.subject.classification	Cardiovascular System & Hematology
dc.subject.classification	General & Internal Medicine
dc.subject.mesh	Adult
dc.subject.mesh	Anxiety
dc.subject.mesh	Anxiety Disorders
dc.subject.mesh	Australia
dc.subject.mesh	Cognitive Behavioral Therapy
dc.subject.mesh	Humans
dc.subject.mesh	Internet
dc.subject.mesh	Randomized Controlled Trials as Topic
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Videoconferencing
dc.subject.mesh	Humans
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Anxiety
dc.subject.mesh	Anxiety Disorders
dc.subject.mesh	Videoconferencing
dc.subject.mesh	Internet
dc.subject.mesh	Adult
dc.subject.mesh	Australia
dc.subject.mesh	Randomized Controlled Trials as Topic
dc.subject.mesh	Cognitive Behavioral Therapy
dc.title	Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial.
dc.type	Journal Article
utslib.citation.volume	23
utslib.location.activity	England
utslib.for	1102 Cardiorespiratory Medicine and Haematology
utslib.for	1103 Clinical Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Clinical Psychology
pubs.organisational-group	/University of Technology Sydney/Centre for Health Technologies (CHT)
utslib.copyright.status	open_access	*
dc.date.updated	2022-09-28T00:15:40Z
pubs.issue	1
pubs.publication-status	Published online
pubs.volume	23
utslib.citation.issue	1

Abstract:

BACKGROUND: Generalized anxiety disorder (GAD) is a chronic mental health condition that results in a significant individual and societal burden. While cognitive behavioral therapy (CBT) is well established as an efficacious treatment for GAD, many patients experience logistical barriers when accessing face-to-face CBT. Remotely delivered treatments remove many of these barriers. Despite emerging evidence demonstrating the efficacy of remotely delivered CBT for GAD, studies examining the efficacy of remote methods for GAD that are analogous to standard face-to-face treatment, in particular synchronous treatments such as CBT delivered via online videoconferencing (VCBT), are needed. METHODS: The authors propose a two-group randomized controlled trial comparing the efficacy of VCBT for GAD against a waitlist control group. The recruitment target will be 78 adults with primary GAD of at least moderate severity. The manualized high-intensity VCBT intervention will be delivered weekly over a 10-week period. After treatment completion, waitlist participants will receive the same VCBT delivered in a brief format (i.e., weekly over a 5-week period). Treatment for both groups will be delivered in real time via an online teleconferencing platform. Outcome measures will be administered at baseline, mid-treatment, post-treatment, and 3-month follow-up. DISCUSSION: This trial will report findings on the efficacy of a remote synchronous high-intensity VCBT intervention for GAD. The results have the potential to contribute towards advancing our knowledge on the evidence base for GAD, as well as increase the dissemination of VCBT for GAD. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12621000786897 . Registered on 22 June 2021.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/162151